Clorox Co. is facing significant financial challenges, with its stock plummeting 34.33% year-to-date and 37% over the past year, making it one of the S&P 500's worst performers. Although the company exceeded revenue expectations, posting $1.43 billion despite an 18.9% annual decline, its heavy dividend payouts and substantial debt raise concerns about its financial viability. In response, investors are selling shares to capture tax losses, with plans to reinvest in Clorox by early 2026, despite facing restrictions on immediate repurchases.